0001493152-19-011476.txt : 20190801 0001493152-19-011476.hdr.sgml : 20190801 20190801120128 ACCESSION NUMBER: 0001493152-19-011476 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190716 FILED AS OF DATE: 20190801 DATE AS OF CHANGE: 20190801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Al-Siddiq Waqaas CENTRAL INDEX KEY: 0001783199 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56074 FILM NUMBER: 19991728 MAIL ADDRESS: STREET 1: C/O 275 SHORELINE DRIVE, SUITE 150 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER NAME: FORMER CONFORMED NAME: Al-Siqqiq Waqaas DATE OF NAME CHANGE: 20190722 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTRICITY INC. CENTRAL INDEX KEY: 0001630113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 472548273 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 75 INTERNATIONAL BLVD., SUITE 300 CITY: TORONTO STATE: A6 ZIP: M9W 6L9 BUSINESS PHONE: (416) 214-3678 MAIL ADDRESS: STREET 1: 75 INTERNATIONAL BLVD., SUITE 300 CITY: TORONTO STATE: A6 ZIP: M9W 6L9 FORMER COMPANY: FORMER CONFORMED NAME: METASOLUTIONS, INC. DATE OF NAME CHANGE: 20150107 3 1 ownership.xml X0206 3 2019-07-16 0 0001630113 BIOTRICITY INC. BTCY 0001783199 Al-Siddiq Waqaas 275 SHORELINE DRIVE, SUITE 150 REDWOOD CITY CA 94065 1 1 1 0 CEO and Chairman of the Board Common Stock 4712336 D Options (Right to buy) 2.20 Common stock 2499998 D Options (Right to buy) 5.44 Common stock 1300000 D Stock options granted in July 2016 pursuant to the 2016 Equity Incentive Plan and vested in equal monthly installments beginning on July 31, 2016. The options expire five years from their vesting date. Stock options granted on January 1, 2018 pursuant to the 2016 Equity Incentive Plan. The options began vesting equally in thirty monthly installments on January 31, 2018 and will continue to vest monthly until June 30, 2020. The options expire five years from the date of vesting and, as of the date of this filing, approximately 40% of the options remain unvested. /s/ Waqaas Al-Siddiq 2019-08-01